Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bentonite is a naturally occurring absorbent aluminum phyllosilicate clay primarily composed of montmorillonite. It is used in medicine as an adsorbent and bulk-forming laxative, and as a base for dermatologic formulations. Its primary mechanism of action is physical adsorption—bentonite binds toxins, drugs (such as aflatoxins), pesticides, and other substances in the gastrointestinal tract or on the skin surface due to its high cation exchange capacity and large surface area. This reduces their bioavailability or facilitates their removal from the body[1][3][5]. In clinical use, it has been studied for preventing aflatoxin toxicity and treating poisonings by acting as a non-specific adsorbent[3]. It is also widely marketed for detoxification purposes and topical applications such as acne treatment or poison ivy exposure[2][5]. However, some commercial bentonite products have been found to contain elevated levels of lead that may pose health risks if ingested or applied topically[4][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on bentonite.